JPRN-jRCTs051180120已完成2 期
Examination of the immunosuppressive drug combination therapy in primary sclerosing cholangitisStudy of the mizoribine and azathioprine combination immunosuppressive therapy - Examination of the immunosuppressive drug combination therapy in primary sclerosing cholangitis
Tajiri Hitoshi0 个研究点目标入组 1 人开始时间: 2019年3月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1
研究概览
简要总结
In this case, the combination therapy with mizoribine and azathioprine was effective, and there were no apparent side effects in this case.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 3age old 至 <= 18age old（—）
- 性别
- All
入选标准
- •1.Primary sclerosing cholangitis
- •2. No condition on primary disease.
- •3.Patients age is 18 years old from 3 years old at the agreement acquisition.
- •3.No condition on primary disease.
- •4.When there are complications such as an esophagus varix, the cirrhosis, it depends on a chief physician judgment
- •5.Written informed consent after adequate explanation and acceptance.
排除标准
- •1.History of hypersensitivity to any ingredients of Bredinin, Imuran, or Azanin.
- •2.Patients with WBC less than 3000/m3.
- •3.Patients with severe degree of allergic diseases.
- •4.Patients who are assessed to be ineligible for this study by the principle investigator.
研究者
相似试验
已完成
3 期
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)PAN or EGPA With FFS=0At Diagnosis or Within the First 15 Days Following Initiation of CorticosteroidsMPANCT00647166Assistance Publique - Hôpitaux de Paris114
进行中（未招募）
1 期
Can suppressing the immune system with azathioprine slow down the progression of Parkinson's disease?Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-003089-14-GBCambridge University Hospitals NHS Foundation Trust and University of Cambridge60
招募中
3 期
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled TrialAzathioprineMethotrexateCrohn DiseaseNCT05040464Centre Hospitalier Universitaire, Amiens166
已完成
3 期
High-dose mizoribine with prednisolone therapyJPRN-jRCTs071180060akanishi Koichi88
已完成
不适用
A combination of prednisolone and mizoribine and a combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial prolideration in children:A randomized controlled trial of efficacy and safetyIgA nephropathy in childrenJPRN-C000000363The Japanese Pediatric IgA Nephropathy of Treatment Study Group80